Expert Witness Profiler | Deep Research and Background Information on Experts

Results for:

Toni Kozhaya Choueiri

Toni Kozhaya Choueiri

Internal Medicine

Boston, Massachusetts
money_back

If you're not satisfied, we don't expect you to pay.

That's our commitment and your guarantee. Simply ask for a refund.

Expert Details
Dr. Toni K. Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute/Brigham and Women’s Hospital and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School. He is the Co-Leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center and President of the Medical Staff at Dana-Farber. He serves on the National Comprehensive Cancer Network (NCCN) Kidney Cancer Panel, the GU Steering Committee (GUSC) Task Force of the National Cancer Institute (NCI), and is Chairman of the Medical and Scientific Steering Committee of the Kidney Cancer Association. He is an expert of Hematology and Oncology from Boston, MA. He has an experience of more than 20 years. He received his medical degree from University Saint Joseph-Faculty Medicine in 2000. He subsequently completed his residency in Internal Medicine and his fellowship in Hematology/Medical Oncology at Cleveland Clinic Foundation. His specialties are internal medicine, hematology, oncology and medical oncology. He is affiliated with Dana Farber Cancer Institute Genitourinary Oncology, Boston, MA. His clinical interests are bladder cancer, genitourinary tumors and renal cell carcinoma (kidney). He is interested in developing novel therapies and biomarkers in GU malignancies, including kidney cancer. His research also focuses on epidemiology, diagnosis and treatment outcomes of GU cancers using large scale approaches such as meta-analyses from available published trials or national databases. He has been funded by the NCI, the Department of Defense (DOD), the American Society of Clinical Oncology (ASCO), the Harvard Kidney Cancer SPORE, and Industry partners. His work has been published in journals such as the New England Journal of Medicine, Nature, Science, Cancer Cell, Journal of American Medical Association, Journal of Clinical Oncology, Lancet Oncology, Clinical Cancer Research, and many others. He has over 450 PubMed-listed publications and is the lead investigator of multiple national and international phase I-III trials in GU cancers. He can speak Chinese and Spanish.

A previous Expert Challenge Study on Toni Kozhaya Choueiri's revealed:

Total Challenges1
Direct Challenges1
Indirect Challenges 0
Preliminary Screening Report

The Preliminary Screening Report (PSR) gives you both a snapshot of an expert’s testimonial history and an accurate assessment of how prolific a testifier that expert has been in the past. Most importantly, it is a tool to help you determine if there is enough information available regarding the expert to justify the investment in a full Expert Witness Profile.

Read More

Expert Challenge Study

Learn about cases where an expert has been challenged under Daubert or their testimony has been criticized by the judge or the opposing party. See the grounds for such challenges, their outcomes (where available) and citations to underlying documents. The Challenge Study includes direct challenges to experts as well as instances where the expert’s testimony/ affidavit was submitted in support or against a motion.

Read More

Expert Witness Profile

The Expert Witness Profile is the most comprehensive and cost-effective background report on an expert witness in the United States today. The product is used by lawyers, law librarians and paralegals practicing in every area of law and by the widest array of organizations: from AMLAW 100 law firms to sole practitioners to national associations of attorneys to expert search firms and even by expert witnesses themselves.